PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 14 filers reported holding PROTEON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $15,000 | -93.9% | 57,600 | -46.8% | 0.00% | -97.2% |
Q4 2018 | $246,000 | +18.8% | 108,294 | +1.9% | 0.04% | +80.0% |
Q3 2018 | $207,000 | +5.6% | 106,241 | +32.8% | 0.02% | +17.6% |
Q2 2018 | $196,000 | +161.3% | 80,011 | +166.5% | 0.02% | +88.9% |
Q1 2018 | $75,000 | – | 30,021 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer VII & Co. Ltd. | 315,101 | $482,000 | 15.66% |
Pharmstandard International S.A. | 1,165,344 | $1,777,000 | 6.16% |
Abingworth LLP | 2,017,872 | $3,027,000 | 2.41% |
MPM ASSET MANAGEMENT LLC | 983,381 | $1,505,000 | 0.65% |
RA Capital Management | 1,337,462 | $2,040,000 | 0.23% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,224,899 | $1,868,000 | 0.10% |
Perceptive Advisors | 334,116 | $518,000 | 0.03% |
WEDBUSH SECURITIES INC | 53,439 | $81,000 | 0.01% |
Baker Brothers Advisors | 298,591 | $455,000 | 0.00% |
FINANCIAL COUNSELORS INC | 50,000 | $78,000 | 0.00% |